Catalyst Wire Dossier Catalyst Wire Dossier

Bexsero

Meningococcal group B vaccine (4CMenB) · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Bexsero, covering 2012-11-16 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection [Phase 2]

See pricing